PHARMOS made a net profit of CZK 11.2 mil with revenues of CZK 10,337 mil in 2019, up by 128% and up by 1.62%, respectively, compared to the previous year.
This translates into a net margin of 0.108%. Historically, between 2006 and 2019, the firm’s net margin reached a high of 0.392% in 2016 and a low of -0.193% in 2012. The average net margin in the last five years amounted to 0.172%.
On the operating level, the EBITDA margin reached 0.556% and EBIT amounted to 0.366% of sales in 2019.
You can see all the company’s data at PHARMOS profile, or you can download a report on the company in the report section.
Helgi Library 
